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 CURRENTOPINION Twenty-four hour intraocular pressure
measurements and home tonometry
Frances Meier-Gibbonsa, Michael S. Berlinb, and Marc To¨teberg-Harmsc
Purpose of review
IOP is the only treatable risk factor contributing to glaucoma and most management and treatment of
glaucoma is based on IOP. However, current IOP measurements are limited to office hours and control of
glaucoma in many patients would benefit from the ability to monitor IOP diurnally so as not to miss abnormal
pressures, which occur outside of office hours Consequently, to improve patient care, the ability to enable
accurate and minimally disruptive diurnal IOP monitoring would improve caring for these patients.
Recent findings
The studies we selected for this review can be divided into three categories: self-/home-tonometry,
continuous invasive intraocular pressure measurements, and continuous noninvasive ocular measurements.
Summary
The desire to obtain better insight in our patients’ true diurnal IOP has led to the development of home-
tonometers, in addition to extraocular and intraocular continuous pressure measurement devices. All of the
devices have respective advantages and disadvantages, but none to date completely fulfills the goal of
providing a true diurnal IOP profile.
Video abstract
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INTRODUCTION
The effects of glaucoma on the eye have fascinated
not only doctors, but also artists for centuries. This
interest is such a curiosity that even the origin of the
name ‘glaucoma’ is not fully explained and until
quite recently, various myths have surrounded the
disease. However, for almost two centuries, it has
been well known that intraocular pressure (IOP)
plays an important role in the onset and progression
of the disease. The intraocular pressure was first
determined manually by palpation until Albrecht
von Graefe designed the first measuring device
(which he ultimately never built) in 1860 [1,2]. Only
following the discovery of the topical anesthetic
cocaine in 1884 was corneal impression tonometry,
which became the basis for modern intraocular
pressure measuring devices, enabled.
If we observe the speed of developments in
modern medicine, it is remarkable to acknowledge
that the gold standard today is a device which was
invented in 1957 by Hans Goldmann – that is, the
applanation tonometer [3,4]. In his first description
of the technique, Goldmann mentioned that the
thickness and consistency of the cornea play a cru-
cial role in determining the accuracy of themeasure-
ments with his device. However, only many years
later with the development of much more precise
and accurate technologies were Goldmann’s
admonitions acknowledged [2].
In the 1970s, nonmedical professions were
interested in performing intraocular pressure meas-
urements. However, as they were not permitted to
use local anesthetics, Bernard Grolman invented the
concept and device for noncontact tonometry,
which remains widely in use currently, but the
accuracy of noncontact tonometry is constrained
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by multiple factors, which influence the resulting
measurements [5].
Understanding the influence of corneal proper-
ties as they relate to the accuracy of conventional
IOP measuring devices, newer instruments such as
the Pascal Contour Tonometer, the Corvis ST
tonometer, and the Ocular Response Analyzer were
developed [6–9]. These are especially useful for
measuring IOP in patients with pathological or
postsurgical alterations of the cornea. An additional
concept Rebound Tonometry, which enables intra-
ocular pressure measurements without anesthesia,
and is especially useful for small corneas, in infants,
or animals [10,11].
Knowing that even with all of these instru-
ments, however, we currently capture only a snap-
shot of the diurnal intraocular pressure, future
developments are likely to enable us to obtain
and analyze full diurnal measurements. From stud-
ies dating back many years, we know that continu-
ous measurements can be obtained either invasively
or with a device placed on the surfaces of the eye
[12]. Invasive techniques are not feasible in practical
ophthalmology and the corneal or scleral surface
techniques are hindered by the interpretation of
interfering factors, for example, blinking artifacts
[13]. However, the development of new surface-
based instruments with improved signal to noise
technologies are in development and will become
commonplace soon.
An alternative to full diurnal IOPmeasurement is
the concept of home-tonometry or self-tonometry,
which allows the patient to independently measure
their intraocularpressure. Suchdevices as theyenable
patients to obtainmultiple IOP ‘snapshots’ per day at
various times of day increase information, useful to
the care of their disease with information, which
can be transmitted telephonically directly to their
physicians and thereby may also play an important
role in discussions related to healthcare costs.
PURPOSE OF THE REVIEW
The gold standard of intraocular pressure measure-
ments has been challenged in recent years by
increased knowledge regarding to the influence of
corneal biomechanics on the accuracyof themeasure-
ments. Newer technologies have been developed,
which allow formore accuratemeasurements, contin-
uous measurements, and self-measurements. With
understanding of the importance of capturing diurnal
variations and allowing the patient to check their
intraocular pressure at home, such devices may also
defer some of the growing costs of glaucomamanage-
ment. The goal of this review is to provide anoverview
of the recent literature (published in the last 12
months) on home tonometry and 24-h tonometry.
MATERIAL AND METHODS
A literature search was conducted using PubMed on
1 August 2017. Search strings were ‘continuous
intraocular pressure,’, ‘self-tonometry,’ ‘home-
tonometry,’ ‘triggerfish,’ and ‘intraocular pressure
contact lens.’ Manuscripts published between 1
August 2016 and 30 July 2017 have been screened.
An additional literature search was performed using
the reference list of these publications.
The results havebeencategorized into self/home-
tonometry, continuous, invasive intraocularpressure
measurements, and continuous, noninvasive ocular
measurements. Manuscripts that were not written in
English or review articles were excluded.
RESULTS
Self-tonometry/home-tonometry
Many studies have been conducted on home-
tonometry/self-tonometry within recent months
[14,15
&
,16–20]. The advancements in self-tonome-
ter devices seem to positively affect patient satisfac-
tion as shown through a study by Mihailovic et al.
[14], which found greater patient satisfaction with
Icare Home (Icare Finland Oy, Vantaa, Finland)
compared with Icare ONE. A study by Mudie et al.
[15
&
] investigated the Icare HOME rebound tonom-
eter. Interestingly, 23% of the participants were not
able to correctly perform home-tonometry correctly
even after training [15
&
]. The study found meaning-
ful agreement between Icare HOME and Goldmann
IOP (Haag-Streit AG, Ko¨niz, Switzerland) (96% were
within 5mmHg) [15
&
]. In addition, IOP measured
with Icare Home showed lower values whenever
KEY POINTS
 Single IOP measurements during office hours are
insufficient for a precise determination of the circadian
IOP pattern.
 Continuous IOP measuring devices (intra-ocular or
extra-ocular) have been under investigation and
development for years; however, at present, no
accurate and cost-effective measuring device has
reached the market.
 Self-tonometry or home-tonometry devices are
promising, but some practical aspects of the
methodology remain in need of improvement,
especially whenever compared with the effectiveness of
GAT measurements.
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compared with Goldmann IOP (1.03mmHg lower)
and a nonoptimal inter-device agreement (intra-
class correlation coefficient 0.641) [21]. In contrast,
another study found that Icare HOME tonometry
measurements tended to overestimate IOP relative
to GAT measurements [17]. A study by Sood and
Ramanathan [16] suggested that in patients with
progressing normal tension glaucoma, IOP spikes
during the out-of-office hours, which could be
revealed by self-tonometry are often missed when-
ever relying solely on office measurements.
Continuous, invasive intraocular pressure
measurements
Koutsonas et al. [22] published the results of the
ARGOS study in 2015. In six patients, a ring-shaped
telemetric IOP sensor was successfully implanted in
the ciliary sulcus after cataract surgery [22]. The
telemetric IOP sensor recorded IOP values similar
to those of Goldmann applanation tonometry [22].
Newer data on this device was published in German
[23]. The patient population from the ARGOS trial
received a reading device 5 months after implanta-
tion of the intraocular, telemetric IOP sensor in
order to self-record their IOP values [23]. The
authors concluded that self-tonometry encourages
patients to be actively involved in the management
of their own illness [23]. However, the authors men-
tioned the importance of the correct analysis and
interpretation of the recorded IOP data by an oph-
thalmologist [23]. Mariacher et al. [24
&
] investigated
a different approach by implanting an IOP trans-
ducer into the suprachoroidal space of rabbits. Using
this approach, the device does not disturb the
anterior chamber and the device can be implanted
without regard to the status of the lens [24
&
].
Biocompatibility was found to be adequate with
minimal fibrosis adjacent to the implantation site,
and with no signs of inflammation, necrosis, or
other pathologies [24
&
]. Clinical assessment con-
firmed good agreement of IOP obtained with the
suprachoroidal sensor and intracameral pressure
measurements [24
&
].
Continuous, non-invasive intraocular
pressure measurements
The Sensimed Triggerfish is a contact lens sensor
that continuouslymeasures change in ocular surface
curvature, which is related to a change in IOP. The
Triggerfish does not record IOP directly [25]. The
results are transmitted wirelessly to a recorder and
can then be analyzed [25,26]. Tojo et al. [27] com-
pared IOP fluctuation in normal-tension glaucoma
versus nonglaucoma eyes using the Sensimed
Triggerfish. They found a larger IOP fluctuation in
normal-tension glaucoma eyes comparedwith those
in nonglaucoma eyes [27]. Aptel et al. [28] evaluated
the effect of selective laser trabeculoplasty on 24-h
IOP in untreated primary open angle glaucoma.
They found an overall reduction in IOP, but no
change in the 24-h IOP profile. Shinmei et al.
[29
&
] looked at 24-h IOP profiles in patients with
obstructive sleep apnea syndrome. They observed an
immediate decrease in IOP during nocturnal sleep in
this group of patients [29
&
].
CONCLUSION
We divided the studies into three distinct groups:
self-tonometry/home-tonometry, continuous, inva-
sive intraocular pressuremeasurements, and contin-
uous, noninvasive ocular measurements. The
majority of the studies are focused on self-tonome-
try or home-tonometry. Such studies compare the
two most commonly used rebound tonometers
(Icare ONE and Icare HOME). Regarding continuous
measurements, the majority of studies use the Sen-
simed ‘Triggerfish’ and only few others use contact
lens sensors. Very few current studies were found,
which continuously measure IOP with an intraocu-
lar device.
Self-tonometry/home-tonometry
The subject of self-tonometry or home-tonometry
has been studied extensively during the past year. It
would be interesting, particularly from the stand-
point of cost-effectiveness, to enable patients to self-
monitor their IOP and subsequently report this data
or have it transmitted directly electronically to
their ophthalmologist.
Applanation tonometry devices are difficult to
use for self-tonometry. Therefore, the majority of
the published studies concentrated on rebound-
tonometry, which is relatively easier to self-perform
and does not require topical anesthesia. It seems
that the second generation of rebound-tonometers
(i.e. the Icare HOME tonometer) has certain advan-
tages over the first generation (i.e. the Icare ONE
tonometer.) One study showed exceptionally inter-
esting facts: There was a good correlation for the
majority of the participants (73 of 100). IOP meas-
urements with the Icare HOME tonometer were
within 5mm Hg of the GAT measurements. The
Icare measurements, however, were consistently
lower than the GAT measurements, especially in
the lower IOP ranges [30].
It is evident that a single IOP measurement,
especially one, which is obtained only during office
hours, does not enable an ideal image of circadian
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IOP changes. Yet, we acknowledge that even nowwe
do not have adequate evidence that the progression
of glaucoma can be slowed down by obtaining
additional IOP measurements. Many other addi-
tional factors influence the outcome of this disease.
However, the psychological factors of self-tonome-
try should not be neglected. For some patients, self-
tonometry might be a viable option to improve
adherence to medication; for others, it might be a
burden and an avoidable additional psychological
stress.
Continuous, invasive intraocular pressure
measurements
Regarding continuous, invasive intraocular IOP
measurements, a lack of studies is present. Further
investigations are necessary to give a sound rec-
ommendation.
Continuous, noninvasive ocular
measurements
The main problem of noninvasive, extraocular devi-
ces used for continuous measurement of IOP is the
fact that we are not certain of what theymeasure. All
studies conclude that the changes identified cannot
be directly translated into IOP. In consideration of
all contact lens sensors used in the last years, only
one has been frequently used in studies: the Sen-
simed Triggerfish (CLS). According to the producer,
it automatically captures changes of ocular dimen-
sions continuously throughout 24h. The data, how-
ever, do not give absolute intraocular pressure
values, but instead show intraocular dimension
changes at the corneoscleral junction. The measure-
ment value is given in an arbitrary unit, not in
millimeters of mercury to which an algorithm
attempts to interpret this data into an IOP equiva-
lent. Hence, all assumptions that Triggerfish actu-
ally measures IOP are imprecise. However, it is
interesting to observe that circadian patterns exist
and that the Triggerfish is able to capture short-term
and long-term fluctuations in ocular dimensions,
which may be related to changes in IOP. Until now,
there is an insufficient number of studies showing a
direct comparison between the Triggerfish and
applanation tonometry or true intracameral IOP
measured by cannulation. In 2017, a study by Vit-
ish-Sharma et al. [31] compared the Triggerfish with
the Tono-Pen XL tonometer and found there was
only a weak correlation. One interesting aspect
might be observed with a continuous measurement:
for years, the influence of body position on IOP has
been discussed. One recently published study
looked at changes measured with a contact lens
sensor and found that there was no significant
contact lens sensor mean values between the posi-
tions (flat versus 308 head up) at night [32]. Further
studies are required, given that the possible influ-
ence of head position on the progression of glau-
coma could lead to scientific rather than theoretical
therapeutic measures.
We conclude that the current studies have dem-
onstrated that there is significant value in improv-
ing technologies and techniques for continuous
noninvasive measurements of IOP. However, at
present, there is no recommendable method which
measures actual IOP and for which reproducibility
and comparability to Goldman IOP has been
proven. Further studies related to the capabilities
and effectiveness of these devices and the introduc-
tion of new devices are necessary and desirable.
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